newdrugapprovals.org
MAA EU -GSK submits diabetes drug Eperzan, albiglutide in EU
MAA EU =marketing authorisation application EU MAR 08 2013 GlaxoSmithKline has announced the submission of a marketing authorisation application for albiglutide, which will have the brand name Eper…